<?xml version="1.0" encoding="UTF-8"?>
<p>The most common adverse effects include mild nausea and vomiting (in around 15% of patients). However, post-marketing surveillance has reported rare but serious adverse neuropsychiatric effects (up to convulsions and encephalitis), severe skin reactions (Stevens-Johnson syndrome), and death [
 <xref rid="B43-pharmaceuticals-13-00096" ref-type="bibr">43</xref>]. Most oseltamivir-related neuropsychiatric events have been reported in children in Japan, where oseltamivir is frequently prescribed [
 <xref rid="B44-pharmaceuticals-13-00096" ref-type="bibr">44</xref>].
</p>
